Positron Emission Tomography (PET)/Computerized tomography (CT)

PROCEDURE4 trials

Sponsors

Robert Flavell, MD, PhD, Rahul Aggarwal, Thomas Hope, University of California, San Francisco

Conditions

Castration-Resistant Prostate CarcinomaGlioma, MalignantLocally Advanced Clear Cell Renal Cell CarcinomaMetastatic Castration-resistant Prostate CancerMetastatic Clear Cell Renal Cell CarcinomaMetastatic Malignant Solid NeoplasmMetastatic Prostate CancerProstate Cancer

Phase 1

PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer

Active, not recruitingNCT05245006

Robert Flavell, MD, PhDMetastatic Castration-resistant Prostate Cancer, Prostate Cancer

Start: 2022-03-18End: 2027-07-31Updated: 2026-03-17

Imaging of Solid Tumors Using 18F-TRX

RecruitingNCT06942104

Rahul AggarwalCastration-Resistant Prostate Carcinoma, Glioma, Malignant, Locally Advanced Clear Cell Renal Cell Carcinoma +7

Start: 2025-07-03End: 2026-09-30Target: 56Updated: 2025-07-18

177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer

RecruitingNCT07145177

University of California, San FranciscoMetastatic Prostate Cancer, Prostate Cancer

Start: 2026-03-16End: 2030-10-31Target: 30Updated: 2026-03-23

Phase 2

Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer

RecruitingNCT06961084

Thomas HopeThyroid Cancer

Start: 2025-07-14End: 2026-03-31Target: 62Updated: 2026-01-07

Related Papers

CD46 targeted 212Pb alpha particle radioimmunotherapy for prostate cancer treatment

Journal of Experimental & Clinical Cancer Research2023-03-1135 citations